APA

Hutson P. H., Finger E. N., Magliaro B. C., Smith S. M., Converso A., Sanderson P. E., Mullins D., Hyde L. A., Eschle B. K., Turnbull Z., Sloan H., Guzzi M., Zhang X., Wang A., Rindgen D., Mazzola R., Vivian J. A., Eddins D., Uslaner J. M., Bednar R., Gambone C., Le-Mair W., Marino M. J., Sachs N., Xu G. & Parmentier-Batteur S. (20120525). The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. : Neuropharmacology.

Chicago

Hutson P H, Finger E N, Magliaro B C, Smith S M, Converso A, Sanderson P E, Mullins D, Hyde L A, Eschle B K, Turnbull Z, Sloan H, Guzzi M, Zhang X, Wang A, Rindgen D, Mazzola R, Vivian J A, Eddins D, Uslaner J M, Bednar R, Gambone C, Le-Mair W, Marino M J, Sachs N, Xu G and Parmentier-Batteur S. 20120525. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. : Neuropharmacology.

Harvard

Hutson P. H., Finger E. N., Magliaro B. C., Smith S. M., Converso A., Sanderson P. E., Mullins D., Hyde L. A., Eschle B. K., Turnbull Z., Sloan H., Guzzi M., Zhang X., Wang A., Rindgen D., Mazzola R., Vivian J. A., Eddins D., Uslaner J. M., Bednar R., Gambone C., Le-Mair W., Marino M. J., Sachs N., Xu G. and Parmentier-Batteur S. (20120525). The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. : Neuropharmacology.

MLA

Hutson P H, Finger E N, Magliaro B C, Smith S M, Converso A, Sanderson P E, Mullins D, Hyde L A, Eschle B K, Turnbull Z, Sloan H, Guzzi M, Zhang X, Wang A, Rindgen D, Mazzola R, Vivian J A, Eddins D, Uslaner J M, Bednar R, Gambone C, Le-Mair W, Marino M J, Sachs N, Xu G and Parmentier-Batteur S. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. : Neuropharmacology. 20120525.